These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 198752)

  • 1. Kinetics of various 99mTc-Sn-pyrophosphate compounds in the rat. II. In vitro studies.
    Schümichen C; Mackenbrock B; Hoffmann G
    Nuklearmedizin; 1977 Aug; 16(4):157-62. PubMed ID: 198752
    [No Abstract]   [Full Text] [Related]  

  • 2. Kinetics of various 99mTc-Sn-pyrophosphate compounds in the rat. I. In vivo studies.
    Schümichen C; Walden J; Hoffmann G
    Nuklearmedizin; 1977 Jul; 16(3):100-3. PubMed ID: 197498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complexing of reduced technetium and tin(II) by chelating phosphate compounds. II. In vitro stability of pyrophosphate and ethane-1, hydroxy-1, diphosphonate (EHDP) complexes.
    Schümichen C; Hohloch M; Hoffmann G
    Nuklearmedizin; 1979 May; 18(2):105-9. PubMed ID: 38437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formation and in-vivo-distribution of different 99mTc-Sn-pyrophosphate complexes.
    Schümichen C; Roth KH; Hoffmann G
    Nucl Med (Stuttg); 1975 Dec; 14(4):323-9. PubMed ID: 2905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complexing of reduced technetium and tin (II) by chelating phosphate compounds. I. Chemical state of technetium.
    Schümichen C; Hohloch H; Schiller A; Pohle W; Hoffmann G
    Nuklearmedizin; 1979 May; 18(2):98-104. PubMed ID: 38438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemistry of 99mTc tracers. II. In vitro conversion of tagged HEDP and pyrophosphate (bone-seekers) into gluconate (renal agent). Effects of Ca and Fe (ii) on in vivo distribution.
    McRae J; Hambright P; Valk P; Bearden AJ
    J Nucl Med; 1976 Mar; 17(3):208-11. PubMed ID: 175138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparative evaluation of the accumulation of 99mTc-labeled phosphate compounds in the bones].
    Atamaniuk NP; Mechev DS
    Eksp Onkol; 1985; 7(1):66-7. PubMed ID: 2983974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical and experimental evaluation of osteotropic radiopharmaceutical preparations].
    Korsunskiĭ VN; Tarasov NF; Koval'chuk ND; Levin VI; Boldyrev PP
    Med Radiol (Mosk); 1980 Sep; 25(9):9-13. PubMed ID: 6252408
    [No Abstract]   [Full Text] [Related]  

  • 9. Technetium-99m-pyrophosphate: studies in vivo and in vitro.
    Kaye M; Silverton S; Rosenthall L
    J Nucl Med; 1975 Jan; 16(1):40-5. PubMed ID: 162947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 99mTc bone scanning agents--II. Adsorption of 99mTc(Sn)pyrophosphate complexes on the mineral phase of bone.
    Kroesbergen J; van Steijn AM; Gelsema WJ; de Ligny CL
    Int J Nucl Med Biol; 1986; 12(6):411-7. PubMed ID: 3011692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone kinetics of calcium-45 and pyrophosphate labeled with technetium-96: an autoradiographic evaluation.
    Guillemart A; Le Pape A; Galy G; Besnard JC
    J Nucl Med; 1980 May; 21(5):466-70. PubMed ID: 6246225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro stabilization of a low-tin bone-imaging agent (99mTc-Sn-HEDP) by ascorbic acid.
    Tofe AJ; Francis MD
    J Nucl Med; 1976 Sep; 17(9):820-5. PubMed ID: 822138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations in tissue distribution of 99mTc-pertechnetate in rats given stannous tin.
    McRae J; Sugar RM; Shipley B; Hook GR
    J Nucl Med; 1974 Mar; 15(3):151-5. PubMed ID: 4813221
    [No Abstract]   [Full Text] [Related]  

  • 14. 99mTc-pyrophosphate for bone imaging.
    Eckelman WC; Reba RC; Kubota H; Stevenson JS
    J Nucl Med; 1974 Apr; 15(4):279-83. PubMed ID: 4361927
    [No Abstract]   [Full Text] [Related]  

  • 15. [Comparative animal experiments concerning the distribution of 99mTc-pyrophosphate, 99mTc-diphosphonate and 85Sr (author's transl)].
    Büll U; Balser D; Frey KW
    Fortschr Geb Rontgenstr Nuklearmed; 1974 Apr; 120(4):481-8. PubMed ID: 4367024
    [No Abstract]   [Full Text] [Related]  

  • 16. Stannous pyrophosphate labeled with technetium-99m for skeletal scintigraphy.
    Hégésippe M; Beydon J; Bardy A; Pannecière C
    J Nucl Biol Med; 1973; 17(3):93-6. PubMed ID: 4355660
    [No Abstract]   [Full Text] [Related]  

  • 17. [Concentration of 99mTc-tin-phosphate complexes in soft tissues].
    Büll U; von Lieven H; Leisner B
    Nucl Med (Stuttg); 1975 Jun; 14(2):91-105. PubMed ID: 170592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone uptake of 99mTc-phosphate via labeled plasma protein.
    Schümichen C; Seifritz R; Hoffmann G
    Nuklearmedizin; 1980 Aug; 19(4):174-7. PubMed ID: 6259628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 99mTc-Sn-pyrophosphate complexes, an investigation of its possible structures.
    Schümichen C; Rörvik-Schümichen K; Hoffmann G
    Nucl Med (Stuttg); 1974 Nov; 13(3):253-7. PubMed ID: 4375276
    [No Abstract]   [Full Text] [Related]  

  • 20. Skeletal uptake of pyrophosphate labeled with technetium-95m and technetium-96, as evaluated by autoradiography.
    Guillemart A; Besnard JC; Le Pape A; Galy G; Fetissoff F
    J Nucl Med; 1978 Aug; 19(8):895-9. PubMed ID: 210266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.